NCT01680341 - Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine | Biotech Hunter

Enrollment

272

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 22, 2013

Study Completion Date

August 22, 2013

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin degludec/insulin aspart

Twice weekly self-titration at intervals of 3-4 days, based upon a single pre-breakfast and pre-dinner SMPG (self-measured plasma glucose) value. For subcutaneous (s.c., under the skin) administration.

DRUG

insulin degludec/insulin aspart

Once weekly self-titration based upon the lowest of 3 pre-breakfast and 3 pre-dinner SMPG (self-measured plasma glucose) values. For subcutaneous (s.c., under the skin) administration.

Trial Locations (45)

12206

Novo Nordisk Investigational Site, Albany

16000

Novo Nordisk Investigational Site, Algiers

16015

Novo Nordisk Investigational Site, Tizi Ouzou

16150

Novo Nordisk Investigational Site, Kota Bharu, Kelantan

20070

Novo Nordisk Investigational Site, Denizli

27070

Novo Nordisk Investigational Site, Gaziantep

29407

Novo Nordisk Investigational Site, Charleston

29572

Novo Nordisk Investigational Site, Myrtle Beach

30024

Novo Nordisk Investigational Site, Suwanee

31000

Novo Nordisk Investigational Site, Oran

31040

Novo Nordisk Investigational Site, Hatay

33324

Novo Nordisk Investigational Site, Plantation

33709

Novo Nordisk Investigational Site, St. Petersburg

34201

Novo Nordisk Investigational Site, Bradenton

34741

Novo Nordisk Investigational Site, Kissimmee

34752

Novo Nordisk Investigational Site, Istanbul

35415

Novo Nordisk Investigational Site, Pohlheim

46123

Novo Nordisk Investigational Site, Avon

46150

Novo Nordisk Investigational Site, Kuala Selangor

46254

Novo Nordisk Investigational Site, Indianapolis

48145

Novo Nordisk Investigational Site, Münster

49620

Novo Nordisk Investigational Site, Buckley

53144

Novo Nordisk Investigational Site, Kenosha

56000

Novo Nordisk Investigational Site, Cheras

56564

Novo Nordisk Investigational Site, Neuwied

60012

Novo Nordisk Investigational Site, Crystal Lake

66386

Novo Nordisk Investigational Site, Saint Ingbert

66780

Novo Nordisk Investigational Site, Rehlingen-Siersburg

71729

Novo Nordisk Investigational Site, Erdmannhausen

75230

Novo Nordisk Investigational Site, Dallas

75251

Novo Nordisk Investigational Site, Dallas

76132

Novo Nordisk Investigational Site, Fort Worth

85395

Novo Nordisk Investigational Site, Goodyear

91978

Novo Nordisk Investigational Site, Spring Valley

92111

Novo Nordisk Investigational Site, San Diego

92801

Novo Nordisk Investigational Site, Anaheim

94904

Novo Nordisk Investigational Site, Greenbrae

98405

Novo Nordisk Investigational Site, Tacoma

98502

Novo Nordisk Investigational Site, Olympia

70461-4231

Novo Nordisk Investigational Site, Slidell

02453

Novo Nordisk Investigational Site, Waltham

03063

Novo Nordisk Investigational Site, Nashua

08648

Novo Nordisk Investigational Site, Lawrenceville

08755-8050

Novo Nordisk Investigational Site, Toms River

07050

Novo Nordisk Investigational Site, Antalya